TY  - JOUR 
AU  - Carriazo, S.
AU  - Perez-Gomez, M. V.
AU  - Cordido Eijo, Adrian
AU  - García González , Miguel Ángel
AU  - Sanz, A. B.
AU  - Ortiz, A.
AU  - Sanchez-Niño, M. D.
PY  - 2019
SN  - 2072-6643
UR  - http://hdl.handle.net/20.500.11940/15402
AB  - Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic nephropathy, and tolvaptan is the only therapy available. However, tolvaptan slows but does not stop disease progression, is marred by polyuria, and most patients...
LA  - eng
KW  - Humans
TI  - Dietary Care for ADPKD Patients: Current Status and Future Directions
DO  - 10.3390/nu11071576
T2  - Nutrients
M2  - 1576
KW  - CHUS
KW  - IDIS
VL  - 11
ER  -